PREDICTORS OF QUALITY OF LIFE IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER DISEASE

A RAFIQ; AR ARSHAD

doi:10.54112/bcsrj.v2023i1.439

Authors

A RAFIQ General Medicine- Combined Military Hospital, Peshawar, Pakistan
AR ARSHAD General Medicine- Combined Military Hospital, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.439

Keywords:

Child-Pugh Score, Chronic Liver Disease, Predictors, Risk factors

Abstract

To determine the predictors of quality of life in patients with decompensated chronic liver disease. A cross-sectional observational research at Combined Military Hospital, Peshawar, from 14-October 2021 to 14-April 2022 included 170 CLD patients. The study assessed HRQOL using the Chronic Liver Disease Questionnaire, a 29-item Likert scale. High CLDQ scores for Abdomen Symptoms (AS), Fatigue (FA), Systemic Symptoms (SS), Activity (AC), Emotional Function (EF), and Worry (WO) predicted greater HRQOL. CLDQ scores ≥5 indicate "good" HRQOL, while <5 indicates "poor." Statistical study utilized IBM SPSS 24 and Chi-Square testing to assess associations (p < 0.05). Regarding disease severity, 43.5% of patients were classified as Child-Pugh class B, while 56.5% were classified as Child-Pugh class C. In terms of the mean CLDQ score, 109 patients (64.1%) exhibited a mean CLDQ score < 5, while 61 patients (35.9%) had a mean CLDQ score >= 5. Notably, a significant association was observed between the mean CLDQ score and Child-Pugh class (P = 0.0001), BMI (P = 0.03), smoking status (P = 0.006), and the presence of cardiovascular diseases (P = 0.03). We identified Child-Pugh Class, BMI, smoking, and cardiovascular diseases as predictors of poor quality of life in decompensated chronic liver disease patients.

Downloads

Download data is not yet available.

References

Afodun, A. M., Eze, E. D., Bakare, A. A., Ukwenya, V. O., Ayinde, T. O., and Quadri, K. K. (2017). Comparative ultrasound review of free intra-peritoneal fluid (ascites). Open Journal of Medical Imaging 7, 229-236.

Asrani, S. K., Devarbhavi, H., Eaton, J., and Kamath, P. S. (2019). Burden of liver diseases in the world. Journal of hepatology 70, 151-171.

Bhandari, B. K., Pradhan, R. R., Pathak, R., Poudyal, S., Paudyal, M. B., Sharma, S., Khadga, P. K., and Khadga, P. (2018). Assessment of validity of SF 36 questionnaire using Nepali language to determine health-related quality of life in patients with chronic liver disease: a pilot study. Cureus 10.

Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., and Kim, W. R. (2021). Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 74, 1014-1048.

Cheemerla, S., and Balakrishnan, M. (2021). Global epidemiology of chronic liver disease. Clinical liver disease 17, 365.

D’Amico, G., Bernardi, M., and Angeli, P. (2022). Towards a new definition of decompensated cirrhosis. Journal of hepatology 76, 202-207.

Duan, X.-Z., Liu, F.-F., Tong, J.-J., Yang, H.-Z., Chen, J., Liu, X.-Y., Mao, Y.-L., Xin, S.-J., and Hu, J.-H. (2013). Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World Journal of Gastroenterology: WJG 19, 1104.

Ezhilarasan, D. (2018). Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab Journal of Gastroenterology 19, 56-64.

Grønkjær, L. L., and Lauridsen, M. M. (2021). Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review. JHEP Reports 3, 100370.

Häuser, W., Janke, K.-H., Klump, B., and Hinz, A. (2011). Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflammatory bowel diseases 17, 621-632.

Khiangte, B., Kothakota, S. R., Sasidharan, M., Kareem, H., Joshi, S., Kumar, V. V., Kanala, J. R., Kumar C, P., and Nair, A. K. (2020). Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease. Indian Journal of Gastroenterology 39, 362-369.

Labenz, C., Toenges, G., Schattenberg, J. M., Nagel, M., Huber, Y., Marquardt, J. U., Galle, P. R., and Wörns, M.-A. (2019). Health-related quality of life in patients with compensated and decompensated liver cirrhosis. European journal of internal medicine 70, 54-59.

Lee, W. M., Stravitz, T. R., and Larson, A. M. (2012). Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 55, 965-967.

Mandorfer, M., and Simbrunner, B. (2021). Prevention of first decompensation in advanced chronic liver disease. Clinics in Liver Disease 25, 291-310.

Montagnese, S., and Bajaj, J. S. (2019). Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues. Drugs 79, 11-16.

Nagel, M., Labenz, C., Wörns, M. A., Marquardt, J., Galle, P. R., Schattenberg, J. M., and Nguyen-Tat, M. (2020). Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives. Health and quality of life outcomes 18, 1-7.

Ridola, L., Nardelli, S., Gioia, S., and Riggio, O. (2018). Quality of life in patients with minimal hepatic encephalopathy. World journal of gastroenterology 24, 5446.

Serper, M., and Volk, M. L. (2018). Current and future applications of telemedicine to optimize the delivery of care in chronic liver disease. Clinical Gastroenterology and Hepatology 16, 157-161. e8.

Souza, N. P. d., Villar, L. M., Garbin, A. J. Í., Rovida, T. A. S., and Garbin, C. A. S. (2015). Assessment of health-related quality of life and related factors in patients with chronic liver disease. Brazilian Journal of Infectious Diseases 19, 590-595.

Thiele, M., Askgaard, G., Timm, H. B., Hamberg, O., and Gluud, L. L. (2013). Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepatitis research and treatment 2013.

Wong, G. L. H., Chan, H. L. Y., Mak, C. W. H., Lee, S. K. Y., Ip, Z. M. Y., Lam, A. T. H., Iu, H. W. H., Leung, J. M. S., Lai, J. W. Y., and Lo, A. O. S. (2013). Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis. Hepatology 58, 1537-1547.

Zhuang, G., Zhang, M., Liu, Y., Guo, Y., Wu, Q., Zhou, K., Ji, Z., and Zhang, X. (2014). Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls. Health and quality of life outcomes 12, 1-9.